Technical Papers

266 Results

Turning “Oh No” into “No Problem”

Turning “Oh No” into “No Problem”

World Courier | 15-Sep-2014 | Technical / White Paper

With all that’s going on in the world right now it’s vital for us all to have plans in place to deal with the unexpected. We need to be prepared individually,...

Viral-Challenge Studies: Regulatory Requirements

Viral-Challenge Studies: Regulatory Requirements

SGS Life Science Services | 15-Sep-2014 | Technical / White Paper

The use of viral-challenge studies as POC studies is gaining wider acceptance. This approach accelerates the selection of a safe and effective dose and...

Developing a Good Plan B

Developing a Good Plan B

World Courier | 01-Sep-2014 | Best Practice

World Courier is continuously looking out for trouble on a local and global scale.  Areas of conflict that might affect transport routes? A hurricane?...

Temperature-Controlled IMP Distribution Challenges

Temperature-Controlled IMP Distribution Challenges

Almac Group | 04-Aug-2014 | Technical / White Paper

UNDERSTANDING THE CHALLENGES OF TEMPERATURE CONTROLLED INVESTIGATIONAL MEDICINAL PRODUCT DISTRIBUTION IN EMERGING MARKETSTemperature deviation within the...

Tightening your Supply Chain against counterfeits

Tightening your Supply Chain against counterfeits

World Courier | 27-Jul-2014 | Technical / White Paper

As today’s global pharmaceutical supply chain grows increasingly longer and more complex, each link provides added opportunity for counterfeiters.While...

Boehringer Ingelheim

Setting the Standard for Plasmid DNA Production

Boehringer Ingelheim Biopharmaceuticals GmbH | 06-Jun-2014 | Data Sheet

Boehringer Ingelheim stands out due to global contract manufacturing excellence in plasmid DNA production. It is one of the world’s leading companies for...

Are there Any Markets left to Emerge?

Are there Any Markets left to Emerge?

World Courier | 02-Jun-2014 | Technical / White Paper

North America, Western Europe and—to a lesser extent—Australasia once served as prime locations for the majority of research. But these Western markets...